MTOR and gastric cancer: By exploring the relationship between target genes and hub genes in oncogenic signaling pathways that they co-occur with, such as BRAF, PIK3CA, APC, MTOR, etc., that have been proven in targeted therapy, we can choose more suitably potential research mechanisms to improve the prognosis of GC.